Tools
Compare any two compounds
We write up the pairs people actually confuse, and there are only so many of those — 82 compounds make more than three thousand possible pairs. This puts any two of them on the same rows, read straight from both profiles. Where we have written the comparison properly, it says so and links you there.
We have written this one up
Semaglutide vs tirzepatide — with sourcing, mechanism and the things a table cannot hold. The rows below are the short version.
| Property | Semaglutide | Tirzepatide |
|---|---|---|
| Evidence | Approved | Approved |
| Category | weight loss | weight loss |
| Regulatory status | Approved by the FDA as a prescription medicine for type 2 diabetes and for chronic weight management. | Approved by the FDA as a prescription medicine for type 2 diabetes and for chronic weight management. |
| Half-life | About 7 days | About 5 days |
| Route | subcutaneous | subcutaneous |
| Frequency reported | Once weekly; Once weekly, raised in steps every four weeks | Once weekly; Once weekly, raised by 2.5 mg every four weeks |
| Dose reported | 250 mcg | 2.5 mg |
| Sold in vials of | 2 mg, 3 mg, 5 mg, 10 mg | 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 60 mg |
| Monitoring markers | 3 recorded | 3 recorded |
| Citations on the profile | 1 | 1 |
Every value is read from the two profiles, and “not recorded” means exactly that — we have not found a source we trust for it, not that the answer is zero. Neither column is a recommendation, and nothing here says which compound suits anyone. Read Semaglutide and Tirzepatide in full before drawing conclusions from a table.
Bioalmanac does not recommend compounds and takes no vendor placement. A comparison describes differences; it does not identify a better option for you.
Keep going
What next
- The written comparisonsThe pairs people genuinely weigh against each other, with prose, sourcing and the nuance a table drops.
- Every compoundThe full profiles these rows are read from, with citations and trial design.
- Running two togetherA different question from choosing between them — what our profiles record about the pair.
- What each costs per mgNormalised across vial sizes, so two compounds can be compared on price as well.
- Compounds by purposeIf you are still deciding what to compare, start from what you are trying to do.
- What the rows mean“Preclinical”, “half-life”, “subcutaneous” — the terms these tables lean on, defined.